Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocolXiao-yi Tang, Hu Chen, Ang Zhang et al.|BMJ Open|2016Cited by 90